Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass Academic Article uri icon

Overview

MeSH Major

  • Anticoagulants
  • Blood Vessel Prosthesis
  • Blood Vessel Prosthesis Implantation
  • Coated Materials, Biocompatible
  • Femoral Artery
  • Heparin
  • Lower Extremity
  • Peripheral Arterial Disease
  • Polytetrafluoroethylene
  • Popliteal Artery

abstract

  • Data from this randomized multicenter study demonstrated improved midterm patency, less bleeding at the suture hole, and lower major adverse events with the FUSION BIOLINE heparin-coated vascular graft compared with standard ePTFE grafts. Although the ultimate long-term benefit of the graft cannot be ascertained with the data currently available, the utility of the FUSION BIOLINE vascular graft appears promising.

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.jvs.2014.10.008

PubMed ID

  • 25720929

Additional Document Info

start page

  • 703

end page

  • 12.e1

volume

  • 61

number

  • 3